Tufts Scientists Receive Grants from Massachusetts Life Sciences Center

Three Tufts scientists and their teams have received capital funding this month from the Massachusetts Life Sciences Center (MLSC) to support research ranging from drug delivery to disease detection technologies....

Read More

MLSC Launches 2021-2022 Capital Programming Round

The MLSC is excited to announce that it is accepting applications for this year’s capital programs: Bits to Bytes, Novel Therapeutics Delivery, Women’s Health, and Research Infrastructure. The deadline to...

Read More

AXONIS Therapeutics Announces $5 Million in Funding; Provides Update on Progress Advancing Novel Therapeutics for Neurological Disorders

AXONIS Therapeutics, Inc., an emerging biotechnology company advancing breakthrough research to develop therapies for neurological disorders, today announced it has secured an additional $5 million in funding. This financing round,...

Read More

Kephera Diagnostics launches CLIA test for quantitative antibody response to COVID-19 vaccination

Kephera Diagnostics announced today the launch of a quantitative test to measure the level of antibodies elicited by vaccination against COVID-19, as well as by COVID-19 infection. The test will...

Read More

Baker-Polito Administration Announces $18 Million in Life Sciences Capital Funding to Support Research Infrastructure, Data Science, and Drug Delivery Projects

Fourteen projects receiving funding to support R&D, innovation in addressing challenges in therapeutic delivery and unlocking potential of data science to answer pressing life sciences questions Today, the Baker-Polito Administration...

Read More

Baker-Polito Administration Announces $3.4 Million to Support STEM Equipment and Teacher Professional Development

Twenty-seven awards will support new and expanded curricula at 93-plus schools, serving more than 38,200 students, and more than 730 teachers receiving professional development Today, the Baker-Polito Administration and the...

Read More

Takeda Unveils Newly Renovated Building at 500 Kendall Street in Cambridge, Massachusetts, Solidifying Presence in Fast-Growing Biopharmaceutical Community

Takeda recently completed renovation of our 500 Kendall Street building in Cambridge, MA. The building will now serve as a centerpiece in Takeda’s interconnected network of buildings across our three...

Read More

Moderna Reaffirms Commitment to Job Creation in Massachusetts

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reaffirmed its commitment to job creation in Massachusetts. Over the last year, Moderna nearly doubled the size...

Read More
X

COVID-19 Updates: mass.gov. Contact MLSC staff currently working offsite.